Sirnaomics Closes $47 Million Series C Financing to Develop RNAi Therapeutics for Treatment of Cancer and Fibrotic Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/2VsdJo5
via IFTTT